Privia Health Group (PRVA) Research Hub

Privia Health Group (PRVA) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-10-26, shares last closed at 22.16 USD (-1.12%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 143.41, market cap 3.21B. This hub links to the full technical, earnings and options research available for PRVA.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Healthcare Information Services)
ExchangeNASDAQ, US
Last close22.16 USD (-1.12%)
52-week range18.915 USD – 28.82 USD
Trend regimeRange
14-day RSI69.4 (Bullish)
Trailing P/E143.41
Market cap3.21B
Dividend yield0.00%

Available research for PRVA

Earnings

PRVA earnings date and last-quarter result: last quarter beat, P/E 143.41. Updated 2026-07-23.

Options: Covered Call

Covered Call on PRVA: how it works, illustrative setup around the real 22.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on PRVA: how it works, illustrative setup around the real 22.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on PRVA: how it works, illustrative setup around the real 22.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

PRVA technical analysis: range, last 22.16 USD, RSI 69.4, 52w range 18.915 USD–28.82 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is PRVA in?

Privia Health Group (PRVA) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.

Is PRVA in an uptrend or downtrend?

As of 2026-10-26, PRVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is PRVA's trailing P/E ratio?

PRVA's trailing P/E is 143.41, with a market cap of 3.21B. See the earnings research page for full valuation detail.